NEW BRUNSWICK, N.J. , Feb. 7, 2018 /PRNewswire/ -- Johnson & Johnson ( NYSE : JNJ) will participate in the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, Feb. 21 , at the Lotte New York Palace in New York City. Dominic Caruso , Executive Vice President, Chief Financial
NEW BRUNSWICK, N.J. , Jan. 31, 2018 /PRNewswire/ -- Johnson & Johnson ( NYSE : JNJ) will participate in the Leerink Partners 7th Annual Global Healthcare Conference on Wednesday, Feb. 14 , at Lotte New York Palace , NY. Dominic Caruso , Executive Vice President, Chief Financial Officer will
2017 Fourth-Quarter Sales of $20.2 Billion Increased 11.5%; EPS was a Loss of $3.99 2017 Full-Year Sales of $76.5 Billion Increased 6.3%, Full-Year EPS was $0.47 Adjusted 2017 Fourth-Quarter EPS was $1.74, an Increase of 10.1%*, and Adjusted 2017 Full-Year EPS was $7.30, an Increase of 8.5%* Continued Sales Acceleration in Fourth Quarter Strong 2017 Full-Year Adjusted EPS Growth of Approximately 8.5%* Company Records Special Item Charge of Approximately $13.6 Billion Related to Recently Enacted Tax Legislation
NEW BRUNSWICK, N.J. , Jan. 2, 2018 /PRNewswire/ -- Johnson & Johnson ( NYSE : JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2018 of $0.84 per share on the company's common stock. The dividend is payable on March 13, 2018 to shareholders of
NEW BRUNSWICK, N.J. , Dec. 19, 2017 /PRNewswire/ -- Johnson & Johnson ( NYSE : JNJ) will participate in the 36 th Annual JP Morgan Health Care Conference on Monday, Jan. 8 , at the Westin St. Francis in San Francisco. Alex Gorsky , Chairman and Chief Executive Officer, will represent the Company
